Fuming Qiu
88 Jiefang Road
Hangzhou, 310009, China
Hangzhou, 310009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Adipocyte-derived LTB4 programs human NKG2A+ γδ T cells as cytotoxic sentinels at the adipose-tumor interface in breast cancer.
Journal: Journal for immunotherapy of cancer
Published: July 07, 2026
Randomized phase 2 trial of a PARP inhibitor TSL-1502 in germline BRCA-mutated, HER2-negative locally advanced/metastatic breast cancer.
Journal: Signal transduction and targeted therapy
Published: September 14, 2025
COPD reshapes the tumor microenvironment of NSCLC and enhances anti-PD-1 therapy response.
Journal: Med (New York, N.Y.)
Published: June 01, 2025
Zinc-copper bimetallic nanoplatforms trigger photothermal-amplified cuproptosis and cGAS-STING activation for enhancing triple-negative breast cancer immunotherapy.
Journal: Journal of nanobiotechnology
Published: November 25, 2024
Case report: Prolonged benefit of ESG401, a Trop2 antibody-drug conjugate, in endocrine-refractory hormone receptor-positive, HER-2 negative metastatic breast cancer.
Journal: Frontiers in oncology
Published: June 05, 2024
Gut microbiota-derived deoxycholic acid shapes an immunosuppressive tumor microenvironment and promotes breast cancer progression.
Journal: Cell metabolism
Published: March 30, 2024
Occult Breast Cancer Presenting as Sternum Pain.
Journal: Diagnostics (Basel, Switzerland)
Published: February 18, 2024
NeoSCORE II: three vs four cycles of neoadjuvant sintilimab + chemotherapy for squamous non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: February 14, 2024
Lerociclib plus fulvestrant in patients with HR+/HER2- locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial.
Journal: Nature communications
Published: December 28, 2023
Last Updated: 09/26/2026